多药耐药相关蛋白8/9/14抗体
MRP 14; MRP-14; MRP 8; MRP8; MRP-8; NIF; P14; P8; Protein S100 A8; Protein S100 A9; S100 A8; S100 A9; S100 calcium binding protein A8; S100 calcium binding protein A9; S100A8; S100A9; Urinary stone pr
FAM50B蛋白抗体
D0H6S2654E; D6S2654E; DNA segment, human D6S2654E; FA50B_HUMAN; FAM50B; Family with sequence similarity 50, member B; Protein FAM50B; Protein XAP 5 like; Protein XAP-5-like; X5L.
减数分裂同源蛋白1抗体
C6orf96; chromosome 6 open reading frame 96; required for meiotic nuclear division 1 homolog (S. cerevisiae); Required for meiotic nuclear division protein 1 homolog; Rmnd1; RMND1_HUMAN.
磷酸化δ连环蛋白抗体
delta 1 Catenin (phospho T310); p-delta 1 Catenin (phospho T310); Cadherin associated Src substrate; Cadherin-associated Src substrate; CAS; Catenin (cadherin associated protein) delta 1; Catenin delt
角膜上皮蛋白TGFBI抗体
AI181842; AI747162; Beta ig; Beta ig h3; Beta ig-h3; BGH3_HUMAN; Big h3; BIGH3; CDB1; CDG2; CDGG1; CSD; CSD1; CSD2; CSD3; EBMD; Kerato epithelin; Kerato-epithelin; LCD1.
复合型表皮生长因子样结构域蛋白5抗体
MEGF 5; MEGF5; Multiple EGF-like domains protein 5; Multiple epidermal growth factor like domains 5; Multiple epidermal growth factor-like domains 5; Multiple epidermal growth factor-like domains prot
Anti-KLHDC2 Polyclonal Antibody
Anti-KLHDC2 Polyclonal Antibody 应用 WB IHC 稀释比例 WB 1:5000-8000. IHC 1:100-300. 交叉反应 Human
微管相关蛋白2a + 2b + 2c抗体
MAP 2; MAP-2; MAP2; MAP2_HUMAN; MAP2A; MAP2B; MAP2C; MAP2R; Microtubule associated protein 2; Microtubule-associated protein 2; MAP2a + MAP2b + 2c; Mtap2.